蔚蓝生物拟4700万元收购艾地盟蔚蓝剩余股权

Group 1 - The company announced that its wholly-owned subsidiary plans to acquire 50% equity of Aidi Alliance Weilan Biotechnology (Shandong) Co., Ltd. for 47 million yuan [1] - Upon completion of the transaction, Aidi Alliance Weilan will become a wholly-owned subsidiary and will be included in the consolidated financial statements [1] - The transaction is subject to approval by the shareholders' meeting, and there is uncertainty regarding whether it will be approved [1] Group 2 - The company's recent activities are primarily focused on equity acquisitions [2]